News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. equity futures rose as markets awaited the Fed decision and details of a reported U.S.-Iran framework.
  • G7 leaders called for an immediate ceasefire in Lebanon.
  • European gas futures fell to one-month lows as traders cut conflict risk premiums.
  • IEA cut its 2026 oil demand outlook and expects gradual Strait of Hormuz flow recovery by 2027.
  • Stellantis, Wayve and Uber partnered to develop and scale Level 4 robotaxi services globally.
  • BOJ deputy Shinichi Uchida warned of broadening price gains, signaling rising central bank concern over inflation.

Latest Articles

Ionis Executive Sells $516K in Stock as Company Advances Multiple Programs

Ionis Executive Sells $516K in Stock as Company Advances Multiple Programs

Patrick R. O’Neil, Executive Vice President, CLO and General Counsel of Ionis Pharmaceuticals, sold 6,179 shares on January 30, 2026, for about $516,153 and recorded the vesting of 11,991 performance-based restricted stock units the prior day. The transactions leave O’Neil with 71,983 shares. Separately, Ionis disclosed recent regulatory and clinic…

Ionis EVP Swayze Sells $512K in Stock as Company Advances Pipeline

Ionis EVP Swayze Sells $512K in Stock as Company Advances Pipeline

Eric Swayze, executive vice president of research at Ionis Pharmaceuticals, sold 6,179 shares on January 30, 2026, for about $512,446. The transaction occurred as Ionis shares trade near a 52-week high and follow a separate vesting-related acquisition of 11,991 shares on January 29. The moves come alongside regulatory approvals, positive clinical d…

Ionis CEO Sells $5.2M in Shares Amid Vesting and Strong Stock Rally

Ionis CEO Sells $5.2M in Shares Amid Vesting and Strong Stock Rally

Ionis Pharmaceuticals CEO Brett P. Monia sold roughly $5.2 million worth of company shares on January 30, 2026, after receiving a larger grant the prior day from vested performance-based restricted stock units. The stock is trading near its 52-week high, supported by recent regulatory approvals and positive Phase 3 trial results, while company fina…

Ionis Executive Disposes $515K in Shares After Recent RSU Vesting

Ionis Executive Disposes $515K in Shares After Recent RSU Vesting

Eugene Schneider, executive vice president and chief clinical development officer at Ionis Pharmaceuticals (IONS), sold 6,179 shares on January 30, 2026, for $515,629, after receiving 11,991 performance-based restricted stock units that vested a day earlier. The sale occurred at prices close to the stock’s 52-week high, while the company has seen s…

PubMatic CEO Disposes of 65,592 Shares, Realizing $477,250; Company Posts Q3 Beat and Management Additions

PubMatic CEO Disposes of 65,592 Shares, Realizing $477,250; Company Posts Q3 Beat and Management Additions

PubMatic CEO Rajeev K. Goel sold a combined 65,592 shares of Class A Common Stock in late January and early February 2026 for roughly $477,250. The trades included transactions executed through The Goel Family Trust under a Rule 10b5-1 plan. Separately, Goel exercised options and converted Class B shares into Class A shares. PubMatic also reported …

Charles R. Schwab Sells $15 Million in SCHW Stock as Company Announces Dividend Hike and Bank Leadership Shift

Charles R. Schwab Sells $15 Million in SCHW Stock as Company Announces Dividend Hike and Bank Leadership Shift

Charles R. Schwab, Co-Chairman of Charles Schwab Corporation (NYSE: SCHW), sold 145,650 shares on January 29, 2026, for roughly $15 million at a weighted average price of $103.1649. The transaction leaves him with substantial direct and indirect holdings. The firm also announced a 19% dividend increase and an internal leadership change at Charles S…

SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology

SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology

SoftBank Corp's unit Saimemory and Intel Corporation have agreed to collaborate on commercializing a new memory architecture called Z-Angle operation memory technology. The partners said the work targets memory chips that combine high capacity, high bandwidth and reduced power consumption, intended for use in artificial intelligence data centers. T…

Solid Biosciences CFO Sells Shares to Cover Taxes After PSU Vesting

Solid Biosciences CFO Sells Shares to Cover Taxes After PSU Vesting

Solid Biosciences Inc. Chief Financial Officer Kevin Tan sold 26,837 shares of common stock on February 2, 2026, in a set of transactions that generated about $172,747. The disposition, reported on a Form 4, was executed to meet withholding tax obligations tied to the recent vesting of performance stock units. The company continues to report clinic…

Japan's Finance Minister Backs PM on Weaker Yen, Citing Textbook Effects

Japan's Finance Minister Backs PM on Weaker Yen, Citing Textbook Effects

Japan's finance minister defended the prime minister's remarks that highlighted potential advantages of a weaker yen, saying the premier was referring to conventional economic teachings. The defense came as the dollar regained levels above 155 yen following a weekend campaign speech in which the prime minister underscored the currency's benefits fo…